Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
JCI Insight|March 8, 2019
Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogrammingPere Llinàs-Arias, Margalida Rosselló-Tortella, Paula López-Serra, et al.
Disease Models & Mechanisms|April 19, 2018
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistanceGorka Ruiz de Garibay, Francesca Mateo, Agostina Stradella, et al.
Cancer Research|June 10, 2026
SMARCB1 Deficiency in Tumors Confers a Vulnerability to H3K27 Demethylase Inhibitors via Autophagy DisruptionAndrea Vilarrubi, Gabriela Guillén, Xiaoyu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2016
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancerAngel Diaz-Lagares, Ana B Crujeiras, Paula Lopez-Serra, et al.
EMBO Molecular Medicine|May 14, 2020
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitorsÁlvaro Lahiguera, Petra Hyroššová, Agnès Figueras, et al.
British Journal of Cancer|January 30, 2023
MmCMS: mouse models' consensus molecular subtypes of colorectal cancerRaheleh Amirkhah, Kathryn Gilroy, Sudhir B Malla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2012
Lurbinectedin (PM01183), a new DNA minor groove binder, inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancerAugust Vidal, Clara Muñoz, María-José Guillén, et al.
Cancer Cell|November 26, 2019
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8<sup>+</sup> T CellsIñaki Etxeberria, Elixabet Bolaños, Jose I Quetglas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2017
Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies <i>B2M</i> Inactivation Impairing ImmunorecognitionCarolina Pereira, Pol Gimenez-Xavier, Eva Pros, et al.
Nature Communications|May 23, 2022
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosisLaura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva, et al.
Pageof 17